How should a new focal asymmetry on a mammogram, absent on prior studies, be evaluated?

Management of New Focal Asymmetry on Mammogram

A new focal asymmetry that was not present on prior mammography requires immediate diagnostic workup with spot compression views (or digital breast tomosynthesis) plus targeted ultrasound, followed by biopsy if the asymmetry persists or shows suspicious features, as this finding carries a 12.8% malignancy risk at screening and 42.9% when biopsy is recommended. 1, 2

Initial Diagnostic Workup

Perform diagnostic mammography with additional views immediately:

• Obtain spot compression views to determine whether the asymmetry persists or represents summation artifact from overlapping normal breast tissue 1, 3
• Digital breast tomosynthesis (DBT) is an equivalent or superior alternative to traditional spot compression views, with improved lesion characterization and potentially reduced radiation exposure 1, 3
• Add magnification views if microcalcifications are present to better characterize any associated calcifications 1, 3

Perform targeted ultrasound concurrently:

• Targeted ultrasound of the area of concern should be performed alongside diagnostic mammography to identify potentially benign causes (such as cysts) or provide a biopsy target 1, 3, 4
• Critical caveat: 23.8% of cancers presenting as developing asymmetry have no sonographic correlate, so normal ultrasound does NOT exclude malignancy 1, 2

Risk Stratification

The malignancy risk varies significantly based on the clinical context:

• Screening-detected developing asymmetry: 12.8% positive predictive value (PPV1) for cancer 2
• When biopsy is recommended: 42.9% positive predictive value (PPV2) for cancer 2
• Overall malignancy rate for developing asymmetries: 15% (95% CI: 11%-21.1%) 5
• Presence of ultrasound or MRI correlate is predictive of malignancy (ultrasound correlate found in 57% of malignant cases vs 36% of benign cases) 5

BI-RADS Classification and Management

After completing diagnostic mammography and ultrasound, assign BI-RADS category:

BI-RADS 0 (Incomplete Assessment)

• Used when additional evaluation is needed before final assessment 6
• Proceed with additional imaging as outlined above 6

BI-RADS 1-3 (Negative, Benign, or Probably Benign)

• Clinical re-examination in 3-6 months 1, 3
• Follow-up imaging with diagnostic mammogram and/or ultrasound every 6-12 months for 1-2 years to confirm stability 1, 3
• If stable over this period, return to routine screening 1
• Important caveat: BI-RADS 3 assessment should only be used after complete diagnostic workup, not on screening examinations 6
• Palpable lesions should not be assigned BI-RADS 3 as this is not supported by scientific data 6

BI-RADS 4-5 (Suspicious or Highly Suggestive of Malignancy)

• Proceed directly to image-guided core needle biopsy (preferred method) 1, 3
• Needle localization excisional biopsy is an alternative if core biopsy is not feasible 1
• BI-RADS 4 lesions have 3-94% malignancy risk 6
• BI-RADS 5 lesions have ≥95% malignancy risk 6

Biopsy Considerations

When the asymmetry persists on diagnostic views:

• If ultrasound shows a correlating mass, perform ultrasound-guided core biopsy 4
• If no ultrasound correlate is identified, perform stereotactic-guided or tomosynthesis-guided core biopsy of the mammographic asymmetry 1, 4
• Place a marker clip at the biopsy site for future correlation 1

Critical pitfall to avoid:

• Do not assume that biopsy of an ultrasound-detected mass addresses the mammographic asymmetry unless there is definitive correlation between the two findings 1
• If the biopsied ultrasound mass does not correspond to the mammographic asymmetry, obtain tissue diagnosis of the original mammographic finding through stereotactic or tomosynthesis-guided biopsy 1

Special Imaging Considerations

MRI may be considered in select cases:

• MRI can be used for problem-solving when mammography and ultrasound are nonspecific 6
• All malignant developing asymmetries that underwent MRI showed correlates (100%), compared to only 28% of benign lesions 5
• MRI is not routinely indicated but may help with biopsy planning if no ultrasound correlate exists and stereotactic biopsy is not feasible 4

Contrast-enhanced mammography:

• Limited data exists for asymmetries, but focal and global asymmetries with suspicious mammographic findings showed statistical significance for malignancy 7
• Non-enhancing asymmetrical density correlated with benign pathology when not associated with other suspicious findings 7

Clinical Context Matters

Low and intermediate-grade DCIS can present as asymmetry without calcifications, so absence of calcifications does not exclude malignancy 1

Associated features that increase suspicion and mandate biopsy: 1

• Suspicious microcalcifications
• Architectural distortion
• Palpable abnormality
• New or increasing size compared to prior studies